Capital Equilibrium Launches a New Level-Funded Pharmacy Benefit Program Powered by Capital Rx

Source: Business Wire, 11/25/2025

Leveraging Capital Rx’s spread-free, full pass-through pharmacy benefit model, Capital Equilibrium is bringing Rx cost savings and renewal stability to the self-funded municipality and commercial markets

Continue reading Capital Equilibrium Launches a New Level-Funded Pharmacy Benefit Program Powered by Capital Rx

Pfizer Completes Acquisition of Metsera

Pfizer logo

November 13, 2025 SOURCE: Pfizer

  • Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape
  • Complements and transforms Pfizer’s Internal Medicine portfolio
  • Positions Pfizer to lead in one of the most dynamic and high-growth therapeutic areas

NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.

Continue reading Pfizer Completes Acquisition of Metsera